Olumiant 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FUAND
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,560
Award facts
- Contract value 100% obligated
- $11,559.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on October 24, 2025, is for the procurement of Olumiant 4 mg tablets (30-count units) by the Defense Logistics Agency (DLA) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is valued at $11,559.61 with a firm fixed price structure and carries an ultimate completion date of October 27, 2025. This award represents a non-set-aside, competitively awarded contract and will be performed at the contractor's Conshohocken location. Olumiant (baricitinib) is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the DLA's ongoing responsibility for supplying pharmaceutical products to military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. This prime contract vehicle functions as a comprehensive pharmaceutical support mechanism enabling the contractor to supply a broad range of medications, vaccines, medical supplies, and specialized healthcare commodities to support military healthcare programs globally. The DLA's Medical Supply Chain utilizes such IDC vehicles to efficiently fulfill federal pharmaceutical procurement requirements while maintaining flexibility in ordering quantities and product specifications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FUAND?
SPE2DB26FUAND was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FUAND worth?
The government has obligated $11,560 on SPE2DB26FUAND.
Is contract SPE2DB26FUAND an order under another contract?
Yes. SPE2DB26FUAND is a delivery order under SPE2DB25D3306, an indefinite delivery contract.
Was contract SPE2DB26FUAND competed?
The extent of competition for SPE2DB26FUAND was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award